Emergent Biosolutions Competitors and Similar CompaniesClear all

Emergent Biosolutions's competitors and similar companies include Valneva.
Emergent Biosolutions
Emergent Biosolutions
Emergent Biosolutions is a biopharmaceutical company that provides vaccines and therapeutics against public health threats.
Valneva
Valneva
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.
Founding Date
Founding Date
1998
Founding Date
2013
Type
Type
Public
Type
Public
Tags
Locations
Locations
Gaithersburg, US HQ
Mississauga, CA
Winnipeg, CA
Dublin, IE
London, GB
Canton, US
Lansing, US
see more
Locations
Saint-Herblain, FR HQ
Wien, AT
Kirkland, CA
Lyon, FR
Solna, SE
Fleet, GB
Livingston, GB
see more
Employees
Employees
90044% decrease
Employees
713
Valuation ($)
Valuation ($)
493.6 m
Valuation ($)
482.5 m

Financial

Revenue (est.)
Revenue (est.)
$742.9m (FY, 2025)
Revenue (est.)
€157.9m (FY, 2025)
Cost of goods
Cost of goods
$326.2m (FY, 2025)
Cost of goods
€8.2m (FY, 2025)
Gross profit
Gross profit
$416.7m (FY, 2025)
Gross profit
€177.7m (FY, 2025)
Net income
Net income
$52.6m (FY, 2025)
Net income
(€115.2m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 34.5m
Total funding raised
$ 51.7m
For sources of this data, please see the company profile

View Company Profiles

Valneva
HQ
Saint-Herblain, FR
Employees
713

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.

View company